Mild to Moderate Ulcerative Colitis
6 clinical trials · Condition
◉ Watch Mild to Moderate Ulcerative Colitis
| Record | Firm | Date |
|---|---|---|
| Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study) (NCT04340895) | Ferring Pharmaceuticals | 2019-10-14 |
| Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis (NCT01201122) | Wolfson Medical Center | 2010-09-01 |
| Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™) (NCT01033305) | Sigmoid Pharma | 2010-03-01 |
| Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis (NCT01039597) | Ore Pharmaceuticals, Inc. | 2009-12-01 |
| A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis (NCT01045018) | EMET Pharmaceuticals, LLC | 2008-01-01 |
Track Mild to Moderate Ulcerative Colitis automatically
Every clearance here is in the API, with alerts when new ones post.